# Clinical Application of Al18F-NOTA-FAPI-04 PET/CT or PET/MRI Imaging in Malignant Tumor,Cardiovascular or Immune Disease

> **NCT07400224** · PHASE1,PHASE2 · RECRUITING · sponsor: **Peking Union Medical College Hospital** · enrollment: 600 (estimated)

## Conditions studied

- Hyperthyroidism, Autoimmune
- Cardiovascular Abnormalities
- Malignant Tumor

## Interventions

- **OTHER:** Al18F-NOTA-FAPI PET/CT(or PET/MRI)

## Key facts

- **NCT ID:** NCT07400224
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-05-10
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2026-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07400224

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07400224, "Clinical Application of Al18F-NOTA-FAPI-04 PET/CT or PET/MRI Imaging in Malignant Tumor,Cardiovascular or Immune Disease". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07400224. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*